Delivery Order SPE2DB22D2206-SPE2DB25FEY45
Award Date
1/3/25
Potential Completion Date
1/27/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,824.28, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $23,824.28 contract is for the supply of the specialized pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
This federal contract award, valued at $29,780.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The $23,824.28 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This federal contract award, valued at $6,161.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract is a firm-fixed-price delivery order with a period of performance through December 31, 2024.
Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a $11,912.14 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty medication, with a completion date of November 26, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, which is a subsidiary of the larger Amerisourcebergen Corporation. The contract has a ceiling value of $3,479.73 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
This federal contract award, valued at $1,401.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract, with a firm fixed price pricing type, and an ultimate completion date of December 26, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation.
AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...